{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"EP Edge Journal Watch","title":"LAAO vs Anticoagulation Explained: WATCHMAN FLX, AF Ablation Recurrence, Post-TAVR Heart Block & ICU AF, Hormones and TdP – EP Edge Journal Watch","html":"<iframe width=\"100%\" height=\"180\" frameborder=\"no\" scrolling=\"no\" seamless src=\"https://share.transistor.fm/e/29bb14cf\"></iframe>","width":"100%","height":180,"duration":856,"description":"EP Edge Journal Watch Podcast — Issue 6 (January 2026)Left Atrial Appendage Occlusion, AF Ablation Insights, Post-TAVR Conduction, ICU Anticoagulation & Translational EP SignalsEP Edge Journal Watch is your high-yield, evidence-driven electrophysiology podcast—designed for busy clinicians who want clinical relevance, mechanistic insight, and practice-changing nuance without wading through every paper.In Issue 6 (January 2026), we anchor the episode around Left Atrial Appendage Occlusion (LAAO)—examining long-term randomized outcomes, implant mechanics that truly matter, and frontier strategies for the most complex patients—then expand into essential EP topics you’ll actually use on rounds.\nWhat’s covered in this episode?1.      LAAO vs Oral Anticoagulation — Long-Term OutcomesWe break down a contemporary randomized trial meta-analysis (including OPTION) examining:Stroke and systemic embolismHemorrhagic vs non-procedural bleedingA provocative mortality signal favoring LAAO\n Practical implications for counseling ablation patients and high-bleeding-risk populations.2.      WATCHMAN FLX Mechanics — Why Compression MattersA deep dive into device sizing and compression:Over-compression thresholdsImpact on peridevice leak (PDL)How this data should influence real-world implant decisions.3.      Persistent LAA Thrombus — Is There a Salvage Path?We discuss a multicenter experience using:Percutaneous aspiration thrombectomyEmbolic protection strategiesSame-session, no-touch LAA closure\n A feasibility signal—not for routine practice, but critical for expert centers facing clinical dead-ends.OPTION Sub-Analysis — Does LAAO Worsen AF Recurrence?Using the largest randomized dataset available:Concomitant vs staged LAAO with ablationAF recurrence, cardioversion, redo ablationWhy “no AF recurrence” ≠ “no stroke risk”.4.      Post-TAVR Conduction DisturbancesA physiology-forward look at:Intraprocedural vs delayed high-grade AV blockHV interval and PR prolongation as rule-out...","thumbnail_url":"https://img.transistorcdn.com/C7iPWVsHlGRm13syn3X4eXGLcqOXyzcuH5XmVutqgHc/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9jMzFi/ZTYxOTI1M2U4NGRj/OGZmZjBhMDFlMjFm/NDQwMC5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}